{"id":"evocalcet","rwe":[{"pmid":"41701341","year":"2026","title":"Evocalcet improved the PTH-calcium setpoint and suppressed parathyroid proliferation in mice model of primary hyperparathyroidism.","finding":"","journal":"Journal of bone and mineral metabolism","studyType":"Clinical Study"},{"pmid":"41365185","year":"2026","title":"Quantitative LC-MS/MS Assay for Evocalcet in Human Plasma: Comparative Pharmacokinetic Evaluation in Fasted and Fed Healthy Chinese Volunteers.","finding":"","journal":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences","studyType":"Clinical Study"},{"pmid":"41260655","year":"2025","title":"Medically Managed Dropped Head Syndrome: Outcomes in Isolated Neck Extensor Myopathy and Primary Hyperparathyroidism-related Myopathy.","finding":"","journal":"Internal medicine (Tokyo, Japan)","studyType":"Clinical Study"},{"pmid":"40769874","year":"2025","title":"Effectiveness of evocalcet for hypercalcemia in patients with primary hyperparathyroidism.","finding":"","journal":"Endocrine journal","studyType":"Clinical Study"},{"pmid":"40471524","year":"2025","title":"Rapid development of diffuse hepatic calcification in a patient with congenital hepatic fibrosis and secondary hyperparathyroidism.","finding":"","journal":"Clinical journal of gastroenterology","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Extracellular calcium-sensing receptor","category":"target"},{"label":"CASR","category":"gene"},{"label":"Active","category":"status"},{"label":"Hypercalcemia in parathyroid carcinoma","category":"indication"},{"label":"Hypercalcemia in primary hyperparathyroidism","category":"indication"},{"label":"Secondary hyperparathyroidism","category":"indication"},{"label":"Kyowa Hakko Kirin Co., Ltd.","category":"company"}],"phase":"marketed","safety":{"safetySignals":[{"llr":163.761,"date":"","count":20,"signal":"Shunt stenosis","source":"DrugCentral FAERS","actionTaken":"Reported 20 times (LLR=164)"},{"llr":98.175,"date":"","count":13,"signal":"Shunt occlusion","source":"DrugCentral FAERS","actionTaken":"Reported 13 times (LLR=98)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"company":"Kyowa Hakko Kirin Co., Ltd.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=EVOCALCET","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:20:21.348075+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Evocalcet","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T00:20:29.089659+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:20:27.661020+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=EVOCALCET","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:20:28.033753+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Calcium sensing receptor positive allosteric modulator","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:20:29.089573+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297621/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:20:28.750874+00:00"}},"allNames":"orkedia","offLabel":[],"synonyms":["evocalcet","orkedia","KHK-7580","KHK7580","MT-4580"],"timeline":[{"date":"2018-03-23","type":"positive","source":"DrugCentral","milestone":"PMDA approval (Kyowa Hakko Kirin Co., Ltd.)"}],"approvals":[{"date":"2018-03-23","orphan":false,"company":"Kyowa Hakko Kirin Co., Ltd.","regulator":"PMDA"}],"brandName":"Orkedia","ecosystem":[{"indication":"Hypercalcemia in parathyroid carcinoma","otherDrugs":[],"globalPrevalence":null},{"indication":"Hypercalcemia in primary hyperparathyroidism","otherDrugs":[],"globalPrevalence":null},{"indication":"Secondary hyperparathyroidism","otherDrugs":[{"name":"etelcalcetide","slug":"etelcalcetide","company":"Kai Pharms Inc"}],"globalPrevalence":null}],"mechanism":{"target":"Extracellular calcium-sensing receptor","targets":[{"gene":"CASR","source":"DrugCentral","target":"Extracellular calcium-sensing receptor","protein":"Extracellular calcium-sensing receptor"}],"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Orkedia (EVOCALCET) is a calcimimetic agent that activates the extracellular calcium-sensing receptor (CaSR), leading to a decrease in parathyroid hormone (PTH) secretion and subsequent reduction in calcium levels."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Evocalcet","title":"Evocalcet","extract":"Evocalcet is a drug for the treatment of hyperparathyroidism. It acts as a calcium-sensing receptor agonist."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5307","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=EVOCALCET","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=EVOCALCET","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Evocalcet","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T11:11:32.479351","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:20:30.371889+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"cinacalcet","drugSlug":"cinacalcet","fdaApproval":"2004-03-08","patentExpiry":"Sep 22, 2026","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"etelcalcetide","drugSlug":"etelcalcetide","fdaApproval":"2017-02-07","patentExpiry":"Jun 27, 2034","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"tryptophan","drugSlug":"tryptophan","fdaApproval":"","relationship":"same-target"}],"genericName":"evocalcet","indications":{"approved":[{"name":"Hypercalcemia in parathyroid carcinoma","source":"DrugCentral","snomedId":47709007,"regulator":"FDA"},{"name":"Hypercalcemia in primary hyperparathyroidism","source":"DrugCentral","snomedId":2243000,"regulator":"FDA"},{"name":"Secondary hyperparathyroidism","source":"DrugCentral","snomedId":91478007,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"cinacalcet","brandName":"cinacalcet","genericName":"cinacalcet","approvalYear":"2004","relationship":"same-target"},{"drugId":"etelcalcetide","brandName":"etelcalcetide","genericName":"etelcalcetide","approvalYear":"2017","relationship":"same-target"},{"drugId":"tryptophan","brandName":"tryptophan","genericName":"tryptophan","approvalYear":"","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT03280264","phase":"PHASE3","title":"Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism","status":"COMPLETED","sponsor":"Kyowa Kirin Co., Ltd.","startDate":"2017-08-30","conditions":["Parathyroid Carcinoma","Primary Hyperparathyroidism"],"enrollment":18,"completionDate":"2019-04-09"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"E58MLH082P","INN_ID":"10098","UMLSCUI":"C4519114","chemblId":"CHEMBL4297621","ChEMBL_ID":"CHEMBL4297621","KEGG_DRUG":"D11063","DRUGBANK_ID":"DB12388","PDB_CHEM_ID":" H43","PUBCHEM_CID":"71242808","IUPHAR_LIGAND_ID":"9042","MESH_SUPPLEMENTAL_RECORD_UI":"C000631688"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Kyowa Hakko Kirin Co., Ltd.","relationship":"Current Owner"}],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"63%"},"publicationCount":63,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Feb 17","pmid":"41701341","title":"Evocalcet improved the PTH-calcium setpoint and suppressed parathyroid proliferation in mice model of primary hyperparathyroidism.","journal":"Journal of bone and mineral metabolism"},{"date":"2026 Feb 1","pmid":"41365185","title":"Quantitative LC-MS/MS Assay for Evocalcet in Human Plasma: Comparative Pharmacokinetic Evaluation in Fasted and Fed Healthy Chinese Volunteers.","journal":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences"},{"date":"2025 Nov 20","pmid":"41260655","title":"Medically Managed Dropped Head Syndrome: Outcomes in Isolated Neck Extensor Myopathy and Primary Hyperparathyroidism-related Myopathy.","journal":"Internal medicine (Tokyo, Japan)"},{"date":"2025 Nov 4","pmid":"40769874","title":"Effectiveness of evocalcet for hypercalcemia in patients with primary hyperparathyroidism.","journal":"Endocrine journal"},{"date":"2025 Aug","pmid":"40471524","title":"Rapid development of diffuse hepatic calcification in a patient with congenital hepatic fibrosis and secondary hyperparathyroidism.","journal":"Clinical journal of gastroenterology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Kyowa Hakko Kirin Co., Ltd.","companyId":"kyowa-hakko-kirin-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":"2018-03-23T00:00:00.000Z","mah":"Kyowa Hakko Kirin Co., Ltd.","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:20:30.371889+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}